ロード中...
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales
Background: Experience in real clinical practice with ceftazidime-avibactam for the treatment of serious infections due to gram−negative bacteria (GNB) other than carbapenem-resistant Enterobacterales (CRE) is very limited. Methods: We carried out a retrospective multicenter study of patients hospit...
保存先:
| 出版年: | Antibiotics (Basel) |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7168189/ https://ncbi.nlm.nih.gov/pubmed/32050434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics9020071 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|